Literature DB >> 18146853

Pellagra, a deficiency disease.

C A ELVEHJEM.   

Abstract

Entities:  

Keywords:  PELLAGRA

Mesh：

Year:  1949        PMID： 18146853

Source DB:  PubMed          Journal:  Proc Am Philos Soc        ISSN： 0003-049X


× No keyword cloud information.
  5 in total

Review 1.  NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns.

Authors:  Hassina Massudi; Ross Grant; Gilles J Guillemin; Nady Braidy
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

Review 2.  NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR.

Authors:  Jun Yoshino; Joseph A Baur; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2017-12-14       Impact factor: 27.287

3.  Nicotinic acid suppresses sebaceous lipogenesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA2 ).

Authors:  Arnold Markovics; Kinga Fanni Tóth; Katalin Eszter Sós; József Magi; Adrienn Gyöngyösi; Zoltán Benyó; Christos C Zouboulis; Tamás Bíró; Attila Oláh
Journal:  J Cell Mol Med       Date:  2019-07-05       Impact factor: 5.310

Review 4.  Implications of NAD+ Metabolism in the Aging Retina and Retinal Degeneration.

Authors:  Ravirajsinh N Jadeja; Menaka C Thounaojam; Manuela Bartoli; Pamela M Martin
Journal:  Oxid Med Cell Longev       Date:  2020-05-09       Impact factor: 6.543

Review 5.  Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations.

Authors:  Angelique Cercillieux; Eleonora Ciarlo; Carles Canto
Journal:  Cell Mol Life Sci       Date:  2022-08-02       Impact factor: 9.207
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.